111

HYPHENS PHARMA

No trades
See on Supercharts

1J5 fundamentals

An in-depth look to HYPHENS PHARMA operating, investing, and financing activities

1J5 free cash flow for H1 24 is -979 k SGD. For 2023, 1J5 free cash flow was 5.53 M SGD and operating cash flow was 5.83 M SGD.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: SGD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth